Worldwide distribution of PSEN1 Met146Leu mutation
Authors:
- A. C. BruniABA. C. Bruni
- L. BernardiLBL. Bernardi
- R. ColaoRCR. Colao
- E. RubinoERE. Rubino
- N. SmirneNSN. Smirne
- F. FrangipaneFFF. Frangipane
- B. TerniBTB. Terni
- S.A.M. CurcioSCS.A.M. Curcio
- M. MirabelliMMM. Mirabelli
- A. ClodomiroACA. Clodomiro
- R. Di LorenzoRLR. Di Lorenzo
- R. MalettaRMR. Maletta
- 9 March 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 74 (10) , 798-806
Abstract
Objective: Large kindreds segregating familial Alzheimer disease (FAD) offer the opportunity of studying clinical variability as observed for presenilin 1 (PSEN1) mutations. Two early-onset FAD (EOFAD) Calabrian families with PSEN1 Met146Leu (ATG/CTG) mutation constitute a unique population descending from a remote common ancestor. Recently, several other EOFAD families with the same mutation have been described worldwide. Methods: We searched for a common founder of the PSEN1 Met146Leu mutation in families with different geographic origins by genealogic and molecular analyses. We also investigated the phenotypic variability at onset in a group of 50 patients (mean age at onset 40.0 ± 4.8 years) by clinical, neuropsychological, and molecular methodologies. Results: EOFAD Met146Leu families from around the world resulted to be related and constitute a single kindred originating from Southern Italy before the 17th century. Phenotypic variability at onset is broad: 4 different clinical presentations may be recognized, 2 classic for AD (memory deficits and spatial and temporal disorientation), whereas the others are expressions of frontal impairment. The apathetic and dysexecutive subgroups could be related to orbital-medial prefrontal cortex and dorsolateral prefrontal cortex dysfunction. Conclusions: Genealogic and molecular findings provided evidence that the PSEN1 Met146Leu families from around the world analyzed in this study are related and represent a single kindred originating from Southern Italy. The marked phenotypic variability might reflect early involvement by the pathologic process of different cortical areas. Although the clinical phenotype is quite variable, the neuropathologic and biochemical characteristics of the lesions account for neurodegenerative processes unmistakably of Alzheimer nature.Keywords
This publication has 40 references indexed in Scilit:
- Novel PSEN1 and PGRN mutations in early-onset familial frontotemporal dementiaNeurobiology of Aging, 2009
- The A431E mutation in PSEN1 causing Familial Alzheimer’s Disease originating in Jalisco State, Mexico: an additional fifteen familiesneurogenetics, 2006
- Novel mutations and repeated findings of mutations in familial Alzheimer diseaseneurogenetics, 2005
- Pick bodies in a family with presenilin‐1 Alzheimer's diseaseAnnals of Neurology, 2004
- A novel presenilin 1 mutation associated with Pick's disease but not β‐amyloid plaquesAnnals of Neurology, 2004
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- A Presenilin-1 Truncating Mutation Is Present in Two Cases with Autopsy-Confirmed Early-Onset Alzheimer DiseaseThe American Journal of Human Genetics, 1998
- Misserise mutation of S182 gene in Italian families with early-onset Alzheimer's diseaseThe Lancet, 1995
- Hierarchical Grouping to Optimize an Objective FunctionJournal of the American Statistical Association, 1963
- Hierarchical Grouping to Optimize an Objective FunctionJournal of the American Statistical Association, 1963